|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
180,310,000 |
Market
Cap: |
41.24(B) |
Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
52
Week Range: |
$191.51 - $228.9 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
38,618 |
449,967 |
Total Sell Value |
$0 |
$0 |
$8,109,687 |
$81,866,696 |
Total People Sold |
0 |
0 |
7 |
8 |
Total Sell Transactions |
0 |
0 |
17 |
69 |
End Date |
2024-04-04 |
2024-01-02 |
2023-07-04 |
2022-07-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sing Amy |
officerTitle |
|
2003-08-15 |
4 |
S |
$5.00 |
$25,240 |
D/D |
(5,000) |
62,107 |
|
- |
|
Sing Amy |
officerTitle |
|
2003-08-14 |
4 |
S |
$4.85 |
$24,250 |
D/D |
(5,000) |
67,107 |
|
- |
|
Lippman Marc E |
Director |
|
2003-08-14 |
4 |
B |
$4.84 |
$24,245 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
Lippman Marc E |
Director |
|
2003-08-14 |
4 |
B |
$4.90 |
$49,000 |
D/D |
10,000 |
47,500 |
2.39 |
- |
|
Sing Amy |
officerTitle |
|
2003-08-04 |
4 |
S |
$4.70 |
$23,500 |
D/D |
(5,000) |
72,107 |
|
- |
|
1805 Records found
|
|
Page 73 of 73 |
|
|